Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

33 results about "Anticholinesterase Agents" patented technology

Certain anticholinesterase agents (phosphacol, “armine,” “pyrophos,” physostigmine) are used in ophthalmology to decrease intraocular pressure in the treatment of glaucoma; galanthamine and eserine in the treatment of myasthenia, myopathy, and other diseases accompanied by reduction in the strength of skeletal muscle contraction.

Combination drug therapy to treat obesity

InactiveUS20050143350A1Undesirable weight gainGood for weight lossBiocideMetabolism disorderCombination drug therapyAnticholinesterase Agents
Provided are methods of achieving desirable weight loss in an overweight or obese individual by administering at least one anticholinesterase agent and at least one antidepressant. The invention also provides for pharmaceutical compositions and kits for simultaneous delivery of at least one anticholinesterase agent and at least one antidepressant.
Owner:THERAKOS INC

Supporting acetylcholine function

This document provides methods and materials related to regulating inflammatory pathways. For example, compositions and kits containing two or more of an anticholinesterase compound, a choline compound, and a carnitine compound and methods for using the compositions and kits described herein to support acetylcholine function to regulate one or more inflammatory pathways are provided.
Owner:NEUROSCI INC

Extraction of protopine from plant, and its manufacture of medicinal preparation and use

The invention discloses a preparation and application of macleyine and other medicine preparation extract from plants, its character lies in: it extracts macleyine with purity of 98% from bloodroot, and part of barberry family and buckthorn plants, and produces solid preparation, injection preparation compound with medicine accessories, the product can be used for curing heart and brain vessel diseases, and AD sufferer, at the same time, the product also has functions of analgesia, anticholinesterase functions and it can advances the bile secretion, and so on.
Owner:北京神农坛医药科技有限公司

Method of screening for genetic predisposition to anticholinesterase therapy

A method of screening for a genetic predisposition to anticholinesterase exposure. The method includes the steps of obtaining a peripheral blood sample, and then analysing serum from the blood sample for BuChE levels and inhibitor-susceptibilities. The DNA of peripheral white blood cells from the blood sample is also screened for the presence of BuChE alleles thereby identifying patients who have a genetic predisposition to anticholinesterase exposure.
Owner:YISSUM RES DEV CO OF THE HEBREWUNIVERSITY OF JERUSALEM LTD

Alkaloid oleraurea in purslane and extraction and separation method thereof

The invention relates to the field of extraction and separation of traditional Chinese medicines, in particular to an alkaloid compound extracted, separated and identified from purslane and an extraction and separation method thereof. The alkaloid compound has a molecular formula of C19H34N2O3 and is named oleraurea. The invention also provides an extraction and separation method of the novel compound, which sequentially adopts 50-percent ethanol reflux extraction, polyamide column chromatography, silica gel column chromatography, an ODS medium pressure column, and Sephadex LH-20 to successfully extract and separate a novel alkaloid compound. The novel compound has anti-cholinesterase and anti-inflammatory effects, and the novel compound and a salt or a derivative thereof can be used as asynthetic precursor for other compounds and a raw material for new drug development and pharmacological activity research, and can be used for preparing anti-cholinesterase and anti-inflammatory drugsor health products.
Owner:LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE

A 19-144, a2-73 and certain anticholinesterase inhibitor compositions and method for Anti-seizure therapy

This invention concerns a dosage form comprising a therapeutically effective amount of A19-144 or A2-73 and a therapeutically effective amount of at least one AED. This invention further encompasses a method of treating a subject in need of such treatment comprising administering a therapeutically effective amount of A19-144 or A2-73 in conjunction with an therapeutically effective amount of an AED.
Owner:ANAVEX LIFE SCI CORP

Novel medical application of isopentenyl isoflavone compounds in licorice roots

The invention discloses novel medical application of isopentenyl isoflavone compounds in licorice roots. Through systematic research on the chemical components and activity screening of the licorice roots, it is discovered that the isopentenyl isoflavone compounds including licoricidin, angustone A and glyasperin D of which the structures are similar have the significant activity on inhibition of cancer cell proliferation and inhibition of protein tyrosine phosphatase 1B (PTP1B), licoricidin and glyasperin D have the significant activity on inhibition of acetylcholine esterase (AChE), and glyasperin D also has the significant activity on inhibition of tyrosinase. On the basis of the discovery, the active compounds or salt, ester and solvent compounds, stereoisomers, tautomer and prodrugs which are acceptable in pharmacy of the active compounds and mixtures of the compounds can be used for preparing anti-cancer drugs, PTP1B inhibitors, antidiabetic drugs, tyrosinase inhibitors, freckle removing and whitening products, AChE inhibitors, anticholinesterase drugs and the like.
Owner:PEKING UNIV

Pyrrole dicarboxylic acid compound in herba portulacae and extraction and separation method and application thereof

The invention relates to the field of extraction and separation of traditional Chinese medicine, in particular to a pyrrole dicarboxylic acid compound extracted, separated and identified from herba portulacae and an extraction and separation method thereof. The molecular formula of the pyrrole dicarboxylic acid compound is C7H8N2O5, and the pyrrole dicarboxylic acid compound is named as 3-(carboxy(methoxy)amino)-1H-pyrrole-2-carboxylic acid. The extraction and separation method of the pyrrole dicarboxylic acid compound is further provided. The compound is prepared by sequentially adopting water for decoction extraction, ethyl acetate for extraction, a silica gel column for chromatography, an ODS medium pressure column and Sephadex LH-20 for purification and a liquid phase for separation. The novel pyrrole dicarboxylic acid compound is structurally determined by means of an approach including 1H NMR, 13C NMR and two-dimensional NMR wave spectrum analysis. The compound has potential activity such as inflammation resistance and cholinesterase resistance, a preparation method is provided, and a leading compound and a theoretical basis are provided for development of new drugs and new components.
Owner:LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE

Ester compound in purslane as well as extraction and separation method and application thereof

The invention relates to the field of traditional Chinese medicine extraction and separation, in particular to a new compound extracted, separated and identified from a purslane medicinal material aswell as an extraction and separation method and application thereof. The invention provides (7E,9E)-6-oxooctadecyl-7,9-dienoic acid ethyl ester extracted from purslane as well as an extraction and separation method and application thereof. The ester compound is prepared by sequentially adopting alcohol decoction extraction, silica gel column chromatography, polyamide column chromatography, ODS medium-pressure column, Sephadex LH-20 purification, and liquid phase separation. The extraction separation method is simple, convenient, rapid and environment-friendly; the compound separated by the method is relatively high in purity; Pharmacological experiments prove that the obtained compound has anti-tumor and anti-cholinesterase effects, so that the new ester compound extracted from purslane and the salt and derivative thereof can be used as natural products to develop new traditional Chinese medicine, and have broad medical application prospects.
Owner:LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE

Ester compound with anti-tumor and anti-cholinesterase activity in purslane and extraction and separation method and application thereof

The invention relates to the field of traditional Chinese medicine extraction and separation, in particular to a new compound extracted, separated and identified from a purslane medicinal material andan extraction and separation method and application thereof. The invention provides 1-ethyl-7-(4-octyl-5-oxo cyclopentyl-1, 3-diene-1-yl) pimelate extracted from purslane and an extraction and separation method and application thereof. The ester compound is prepared by sequentially adopting alcohol decoction extraction, silica gel column chromatography, polyamide column chromatography, ODS medium-pressure column and Sephadex LH-20 purification and liquid phase separation. The extraction and separation method is simple, convenient, rapid and environment-friendly, the compound separated by themethod is relatively high in purity, and pharmacological experiments prove that the obtained compound has anti-tumor and anti-cholinesterase effects so that the new ester compound extracted from purslane and the salt and derivative thereof can be used as natural products to develop new traditional Chinese medicine, and wide medical application prospects are realized.
Owner:LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE

Compound Olerafuran A in herba portulacae as well as extraction and separation method and application of compound Olerafuran A

The invention relates to the field of traditional Chinese medicine extraction and separation, in particular to a new compound extracted, separated and identified from herba portulacae medicinal material as well as an extraction and separation method and application thereof. The invention provides a compound Olerafuran A extracted from herba portulacae as well as an extraction and separation methodand application of the compound Olerafuran A. The ester compound is prepared by sequentially adopting alcohol decoction extraction, silica gel column chromatography, polyamide column chromatography,ODS medium-pressure column and Sephadex LH-20 purification and liquid phase separation, the extraction and separation method is simple, convenient, rapid and environment-friendly, and the compound separated by the method is relatively high in purity. Pharmacological experiments prove that the obtained compound has anti-tumor and anti-cholinesterase effects, so that the compound Olerafuran A extracted from herba portulacae as well as a salt and a derivative thereof can be used as natural products to develop new traditional Chinese medicine and have a wide medical application prospect.
Owner:LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE

Muscarinic combination of a selective m2-antagonist and a peripheral non-selective antagonist for treating hypocholinergic disorders

A combination of a muscarinic receptor antagonist consisting of a M2-receptor antagonist and of a non-selective, peripheral anticholinergic agent, and optionally an anticholinesterase inhibitor, and use of the same for treatment of hypocholinergic type disorders such as Alzheimer type dementia, schizophrenia, schizophrenia associated dementia, and schizoaffective disorders.
Owner:CHASE PHARMA CORP

Three alkaloid compounds in purslane and extraction and separation method thereof

ActiveCN113321618AAnti-inflammatoryHas anticholinesterase effectOrganic chemistryAntipyreticChemical compoundDextran
The invention relates to the field of traditional Chinese medicine extraction and separation, in particular to three alkaloid compounds extracted, separated and identified from purslane and an extraction and separation method thereof. The molecular formulas of the three alkaloid compounds are respectively C16H15NO5, C13H11NO3 and C14H13NO3, and the three alkaloid compounds are respectively named as 4,9,10-trihydroxy-2-methoxy-6,7-dihydrodibenzo [b,e]azocin-12(5H)-one, 9,10-dihydroxy-5,6-dihydro-11H-benzo[d]pyrrolo[1,2-a]azepin-11-one, and 8,9-dihydroxy-6,11-dihydro-5H-benzo[d] pyrrolo[1,2-a]azepine-3-carbaldehyde. The invention further provides an extraction and separation method of the alkaloid compounds. The extraction and separation method sequentially comprises the steps of ethanol reflux extraction, silica gel column chromatography, ODS medium-pressure column and hydroxypropyl dextran column chromatography purification and HPLC separation and preparation. The structures of the novel alkaloid compounds are determined by adopting methods of 1H-NMR, 13C-NMR and UHPLC-ESI-TOF-MS. The three compounds have potential anti-inflammatory and anti-cholinesterase activities and the like, a preparation method is provided, and a primer and a theoretical basis are provided for developing new drugs and new components.
Owner:LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE

Lignan compound in herba portulacae and extraction and separation method and application of lignan compound

The invention relates to the field of traditional Chinese medicine extraction and separation, in particular to a new compound extracted, separated and identified from a purslane medicinal material andan extraction and separation method and application thereof. The invention provides a lignan compound olealignan A extracted from portulaca oleracea and an extraction and separation method and application thereof. The ester compound is prepared by sequentially adopting alcohol decoction extraction, silica gel column chromatography, polyamide column chromatography, ODS medium-pressure column and Sephadex LH-20 purification and liquid phase separation. The extraction and separation method is simple, convenient, quick and environment-friendly, and the compound separated by the method is relatively high in purity and pharmacological experiments prove that the obtained compound has anti-tumor and anti-cholinesterase effects so that the lignan compound olealignan A extracted from purslane and the salt and derivative thereof can be used as natural products to develop new traditional Chinese medicine, and have a wide medical application prospect.
Owner:LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE

Treating of side-effects resulting from chemodenervation

The present disclosure relates generally to methods of restoring neuromuscular transmission by locally administering an effective dose of a composition comprising an anticholinesterase to a non-responsive muscle. The disclosure also relates to methods of reversing a neurotoxin-induced muscle paralysis or muscle weakness, the method comprising locally administering a composition comprising an anticholinesterase to the patient.
Owner:DELNOVA INC

A kind of lignan compound in purslane and its extraction and separation method and application

The invention relates to the field of extraction and separation of traditional Chinese medicines, in particular to a new compound extracted, separated and identified from purslane medicinal material and its extraction and separation method and application. The invention provides a lignan compound olealignan A extracted from purslane and its extraction and separation method and application. The ester compound is sequentially extracted by alcohol decoction, silica gel column chromatography, polyamide column chromatography, ODS medium-pressure column and Sephadex LH-20 purification, liquid phase separation preparation, the extraction and separation method is simple, fast, and environmentally friendly, and the purity of the compound obtained by this method is relatively high. Pharmacological experiments have proved that the obtained compound has anti-tumor and anti-cholesterol Alkaline esterase, so the lignan compound olealignan A extracted from purslane and its salts and derivatives can be used as natural products to develop new traditional Chinese medicines, and have broad medical application prospects.
Owner:LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE

Alkaloid oleraurea in purslane and its extraction and separation method

The invention relates to the field of extraction and separation of traditional Chinese medicines, in particular to an alkaloid compound extracted, separated and identified from purslane and an extraction and separation method thereof. The alkaloid compound has a molecular formula of C19H34N2O3 and is named oleraurea. The invention also provides an extraction and separation method of the novel compound, which sequentially adopts 50-percent ethanol reflux extraction, polyamide column chromatography, silica gel column chromatography, an ODS medium pressure column, and Sephadex LH-20 to successfully extract and separate a novel alkaloid compound. The novel compound has anti-cholinesterase and anti-inflammatory effects, and the novel compound and a salt or a derivative thereof can be used as asynthetic precursor for other compounds and a raw material for new drug development and pharmacological activity research, and can be used for preparing anti-cholinesterase and anti-inflammatory drugsor health products.
Owner:LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE

Compound olerafuran A in purslane and its extraction and separation method and use

The invention relates to the field of extraction and separation of traditional Chinese medicines, in particular to a new compound extracted, separated and identified from purslane medicinal material and its extraction and separation method and application. The invention provides a compound Olerafuran A extracted from purslane and its extraction and separation method and application. The ester compound is sequentially extracted by alcohol decoction, silica gel column chromatography, polyamide column chromatography, and ODS medium pressure column. and Sephadex LH-20 purification, liquid phase separation and preparation, the extraction and separation method is simple, fast, and environmentally friendly, and the compound obtained by this method is relatively high in purity, and pharmacological experiments have proved that the obtained compound has anti-tumor and anti-cholinesterase effects Therefore, the compound Olerafuran A extracted from purslane and its salts and derivatives can be used as natural products to develop new traditional Chinese medicines, and have broad medical application prospects.
Owner:LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE

Nitrogen-containing organic acid in purslane and extraction and separation method thereof

The invention relates to the field of extraction and separation of traditional Chinese medicines, in particular to a nitrogen-containing organic acid compound extracted, separated and identified from purslane and an extraction and separation method thereof. The molecular formula of the nitrogen-containing organic acid compound is C16H30N2O5, and the nitrogen-containing organic acid compound is named as 5-(diethylamino)-2-(3-(diethylamino)-3-oxopropyl)-2-hydroxy-5-oxopentanoic acid. The invention also provides the extraction and separation method of the nitrogen-containing organic acid compound. The nitrogen-containing organic acid compound is prepared by sequentially adopting water decoction extraction, silica gel column chromatography, ethyl acetate extraction, ODS medium-pressure column, SI medium-pressure column and liquid phase separation. The structure of the nitrogen-containing organic acid compound is determined to be the nitrogen-containing organic acid compound by adopting 1H-NMR, 13C-NMR and two-dimensional nuclear magnetic spectrum analysis methods. The compound has potential anti-cholinesterase activity, the preparation method is provided, and a primer and a theoretical basis are provided for developing new drugs and new components.
Owner:LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE

Organic acid compound in purslane and extraction and separation method thereof

The invention relates to the field of extraction and separation of traditional Chinese medicines, in particular to an organic acid compound extracted, separated and identified from purslane and an extraction and separation method of the organic acid compound. The molecular formula of the organic acid compound is C15H24O2, and the organic acid compound is named as (7E, 9E, 12E)-pentadecyl-7, 9, 12-trienoic acid, and the structural formula of the organic acid compound is shown in the description. The invention further provides an extraction and separation method of the organic acid compound. The extraction and separation method sequentially comprises the steps of water decoction extraction, silica gel column chromatography, macroporous resin column chromatography, ODS medium-pressure column chromatography, silica gel column chromatography, Sephadex LH-20 purification and HPLC separation preparation. The structure of the compound is determined to be a novel organic acid compound by 1H-NMR, 13C-NMR and two-dimensional nuclear magnetic spectrum analysis methods. The compound has potential anti-inflammatory and anti-cholinesterase activities and the like, a preparation method is provided, and a primer and a theoretical basis are provided for developing new drugs and new components.
Owner:LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE

An ester compound with anti-tumor and anti-cholinesterase activity in purslane and its extraction and separation method and application

The invention relates to the field of extraction and separation of traditional Chinese medicines, in particular to a new compound extracted, separated and identified from purslane medicinal material and its extraction and separation method and application. The invention provides a kind of 1-ethyl-7-(4-octyl-5-oxocyclopent-1,3-diene-1-yl)pimelate extracted from purslane and its Extraction and separation method and application, the ester compound is sequentially prepared by alcohol decoction extraction, silica gel column chromatography, polyamide column chromatography, ODS medium pressure column and Sephadex LH‑20 purification, and liquid phase separation. The extraction and separation method is simple, It is fast, environmentally friendly, and the purity of the compound separated by this method is high. Pharmacological experiments have proved that the compound obtained has anti-tumor and anti-cholinesterase effects. Therefore, the described new ester compound extracted from purslane Its salts and derivatives can be used as natural products to develop new traditional Chinese medicines, and have broad medical application prospects.
Owner:LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE

A kind of ester compound in purslane and its extraction and separation method and application

The invention relates to the field of extraction and separation of traditional Chinese medicines, in particular to a new compound extracted, separated and identified from purslane medicinal material and its extraction and separation method and application. The present invention provides (7E,9E)-6-oxoctadecyl-7,9-dienoic acid ethyl ester extracted from purslane and its extraction and separation method and application. The ester compounds are sequentially Using alcohol decoction extraction, silica gel column chromatography, polyamide column chromatography, ODS medium pressure column and Sephadex LH-20 purification, liquid phase separation and preparation, the extraction and separation method is simple, fast, and environmentally friendly, and the obtained by this method separation The compound has high purity, and pharmacological experiments have proved that the obtained compound has anti-tumor and anti-cholinesterase effects, so the described new ester compound extracted from purslane and its salt and derivatives can be developed as natural products New traditional Chinese medicine has broad prospects for medical application.
Owner:LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE

Polyaryl compound in purslane and extraction and separation method thereof

The invention relates to the field of extraction and separation of traditional Chinese medicines, in particular to a novel polyaryl compound extracted, separated and identified from purslane and an extraction and separation method thereof. The molecular formula of the polyaryl compound is C60H58O, 1,1'-oxybis(2-((R)-1-phenylethyl)-4,5-bis ((S)-1-phenylethyl)phenyl). The invention further provides an extraction and separation method of the polyaryl compound. The polyaryl compound is prepared by sequentially adopting alcohol solvent decoction reflux extraction, macroporous resin column chromatography, silica gel column chromatography, ODS medium-pressure column and hydroxypropyl dextran column chromatography purification and liquid phase separation. The structure of the compound is determined by methods such as 1H-NMR, 13C-NMR, UHPLC-ESI-Q-TOF-MS and the like. The compound has potential neuro-protection activity, cholinesterase resistance activity and the like, a preparation method is provided, and a primer and a theoretical basis are provided for developing new drugs and new components.
Owner:LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE

Three kinds of alkaloid compounds in purslane and their extraction and separation methods

The invention relates to the field of extraction and separation of traditional Chinese medicines, in particular to three alkaloid compounds extracted, separated and identified from purslane and an extraction and separation method thereof. Described three kinds of alkaloid compounds, molecular formula is respectively C 16 h 15 NO 5 , C 13 h 11 NO 3 , C 14 h 13 NO 3 , named as 4,9,10-trihydroxy-2-methoxy-6,7-dihydrodibenzo[b,e]azocin-12(5H)-one, 9,10-dihydroxy-5,6-dihydro-11H-benzo [d]pyrrolo[1,2‑a]azepin‑11‑one, 8,9‑dihydroxy‑6,11‑dihydro‑5H‑benzo[d]pyrrolo[1,2‑a]azepine‑3‑carbaldehyde. It also provides an extraction and separation method for the above-mentioned alkaloid compounds, which is sequentially prepared by ethanol reflux extraction, silica gel column chromatography, ODS medium pressure column and hydroxypropyl dextran column chromatography, and HPLC separation and preparation. Its structure adopts 1 H-NMR, 13 C-NMR and UHPLC-ESI-TOF-MS methods identified three new alkaloid compounds. The three compounds have potential anti-inflammatory and anti-cholinesterase activities, and provide preparation methods to provide lead and theoretical basis for the development of new drugs and new ingredients.
Owner:LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE

Ferulic acid derivative as well as preparation method and application thereof

The invention discloses a ferulic acid derivative as well as a preparation method and application thereof, specifically, ferulic acid is taken as a raw material, ferulic acid and methanol are subjected to reflux under the condition of concentrated sulfuric acid to obtain ferulic acid methyl ester, the ferulic acid methyl ester reacts with different substituted carbamoyl chloride to generate a ferulic acid carbamate substituted derivative, and the ferulic acid carbamate substituted derivative is obtained. Further removing a methyl protecting group under the action of lithium hydroxide to expose a carboxyl terminal, and finally reacting with different substituted aniline under the actions of HATU and DIPEA to generate the target ferulic acid derivative. In-vitro cholinesterase activity tests are carried out on the synthesized ferulic acid derivative, most of the compounds have inhibitory activity on cholinesterase, and the compound is an ideal cholinesterase-resistant chemical entity and has important significance in treatment of Alzheimer's disease.
Owner:XIAN MEDICAL UNIV

Application of plant compounds in preparation of drugs for preventing and treating Alzheimer's disease

The invention relates to the technical field of biological medicines, in particular to application of plant compounds in preparation of drugs for preventing and treating Alzheimer's disease. Accordingto the application, three plant compounds of epigallocatechin 3-gallate, albumin and melanin with the highest binding affinity are selected; then Alzheimer's disease induced by centralized administration of colchicine in rats is studied by using, and molecular docking is simulated through computer simulation to obtain core structure parts of four proteins AChE, AKT-1, BACE-1 and COX-2 docked by plant compounds, which proves that the four proteins related to AD can be used as potential targets. Epigallocatechin 3-gallate, albumin and melanin not only have potential anti-inflammatory, antioxidant and anti-cholinesterase characteristics, but also can inhibit ROS rise and protect the brain from tau excessive phosphorylation and A beta plaque deposition, and can be used as a potential drug forpreventing and treating AD.
Owner:SHANGHAI JIAO TONG UNIV +2
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products